Nobuhisa Hagiwara
Department Other, Other Position |
|
Article types | Original article |
Language | English |
Peer review | Peer reviewed |
Title | Design and rationale of the STroke secondary prevention with catheter ABLation and EDoxaban clinical trial in patients with non-valvular atrial fibrillation: The STABLED study. |
Journal | Formal name:Journal of cardiology : Official Journal of the Japanese College of Cardiology Abbreviation:J Cardiol ISSN code:0914-5087/1876-4738 |
Domestic / Foregin | Domestic |
Publisher | Elsevier |
Volume, Issue, Page | pp.in press |
Author and coauthor | Sakamoto Yuki, Nishiyama Yasuhiro, Iwasaki Yu-Ki, Daida Hiroyuki, Toyoda Kazunori, Kitagawa Kazuo, Okumura Ken, Kusano Kengo, Hagiwara Nobuhisa, Fujimoto Shigeru, Miyamoto Susumu, Otsuka Toshiaki, Iguchi Yasuyuki, Kanamaru Takuya, Yamamoto Teppei, Kaburagi Jumpei, Kimura Tetsuya, Matsumoto Takuyuki, Kimura Kazumi, Shimizu Wataru, |
Publication date | 2019/07 |
Summary | CONCLUSION:
This study will investigate the effectiveness and safety of CA and basic anticoagulation treatment with edoxaban for patients with NVAF who have suffered a recent ischemic stroke. The aim is to determine the best evidence for an optimal treatment strategy for patients with NVAF and recent stroke. |
DOI | 10.1016/j.jjcc.2019.06.002 |
PMID | 31337525 |